Last reviewed · How we verify
Loxonin (LOXOPROFEN)
At a glance
| Generic name | LOXOPROFEN |
|---|---|
| Sponsor | Lead Chemical Co., Ltd. |
| Drug class | loxoprofen |
| Target | Prostaglandin G/H synthase 1 |
| Modality | Small molecule |
| Therapeutic area | Immunology |
| Phase | FDA-approved |
| First approval | 1986 |
Approved indications
- Rheumatoid arthritis
Common side effects
Key clinical trials
- Nitroglycerin Ointment for Pain Relief After Endoscopic Hemorrhoid Band Ligation (PHASE4)
- The Analgesic Efficacy and Safety of Loxoprofen Sodium Patch in Patients With Herpes Zoster (NA)
- Minimum Effective Dose of Incisional Local Infiltration Betamethasone for the Prevention of Pain After Spinal Surgery (NA)
- Multimodal Imaging and Biospecimen Collection for Low Back Pain (LBPB)
- An Bioequivalence Study of Loxoprofen Sodium Patches in Healthy Volunteers (PHASE1)
- A Trial of HRF2105 Patch in Relieving Pain of Osteoarthritis (PHASE2)
- Effects of Shinbaro Pharmacopuncture in Sciatic Pain Patients With Lumbar Disc Herniation (NA)
- Autologous Platelet Rich Plasma on Low Back Pain (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |